Molecular Partners Stock Pops Into Holiday Pause as Traders Eye Cancer-Drug Data
Molecular Partners shares closed at CHF 3.15 on Friday, up 9.38%, ahead of a market pause for Whit Monday and Memorial Day. The company will present first-in-human data for its lead Radio-DARPin candidate MP0712 at a Basel meeting on May 29. Q1 filings showed no revenue, R&D costs of CHF 9.45 million, and a net loss of CHF 13.14 million. Cash reserves stood at CHF 79 million at March-end.